Biomm S.A - Asset Resilience Ratio

Latest as of September 2025: 14.65%

Biomm S.A (BIOM3) has an Asset Resilience Ratio of 14.65% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Biomm S.A (BIOM3) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

R$71.03 Million

≈ $13.94 Million USD Cash + Short-term Investments

Total Assets

R$485.03 Million

≈ $95.17 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Biomm S.A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Biomm S.A total assets.

Liquid Assets Composition Over Time

This chart breaks down Biomm S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore BIOM3 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	R$11.50 Million	2.37%
Short-term Investments	R$59.53 Million	12.27%
Total Liquid Assets	R$71.03 Million	14.65%

Asset Resilience Insights

Moderate Liquidity: Biomm S.A has 14.65% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Biomm S.A Industry Peers by Asset Resilience Ratio

Compare Biomm S.A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Genscript Biotech Corporation F:G51	Biotechnology	13.79%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
BB Biotech AG SW:BION	Biotechnology	92.97%
89bio Inc NASDAQ:ETNB	Biotechnology	71.60%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	2.66%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%

Annual Asset Resilience Ratio for Biomm S.A (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Biomm S.A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	29.70%	R$138.28 Million ≈ $27.13 Million	R$465.66 Million ≈ $91.37 Million	+14.47pp
2023-12-31	15.22%	R$52.47 Million ≈ $10.29 Million	R$344.70 Million ≈ $67.64 Million	-9.16pp
2022-12-31	24.38%	R$98.78 Million ≈ $19.38 Million	R$405.09 Million ≈ $79.49 Million	+9.69pp
2021-12-31	14.69%	R$54.34 Million ≈ $10.66 Million	R$369.83 Million ≈ $72.57 Million	-10.23pp
2020-12-31	24.93%	R$108.43 Million ≈ $21.28 Million	R$434.97 Million ≈ $85.35 Million	-1.88pp
2019-12-31	26.80%	R$104.21 Million ≈ $20.45 Million	R$388.77 Million ≈ $76.28 Million	+2.25pp
2018-12-31	24.55%	R$75.06 Million ≈ $14.73 Million	R$305.68 Million ≈ $59.98 Million	+11.50pp
2017-12-31	13.06%	R$34.26 Million ≈ $6.72 Million	R$262.39 Million ≈ $51.49 Million	-3.19pp
2016-12-31	16.25%	R$38.57 Million ≈ $7.57 Million	R$237.38 Million ≈ $46.58 Million	-22.95pp
2015-12-31	39.20%	R$90.03 Million ≈ $17.67 Million	R$229.67 Million ≈ $45.07 Million	-17.51pp
2014-12-31	56.71%	R$101.83 Million ≈ $19.98 Million	R$179.56 Million ≈ $35.23 Million	+4.71pp
2013-12-31	52.00%	R$71.80 Million ≈ $14.09 Million	R$138.08 Million ≈ $27.09 Million	--

pp = percentage points

About Biomm S.A

SA:BIOM3 Brazil Biotechnology

Market Cap

$168.09 Million

R$856.63 Million BRL

Market Cap Rank

#17302 Global

#164 in Brazil

Share Price

R$6.26

Change (1 day)

+0.00%

52-Week Range

R$5.45 - R$10.30

All Time High

R$23.65